J Infect Dis. 1992 Feb;165(2):381-4.

Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.

Marshall GS, Rabalais GP, Stout GG, Waldeyer SL.

Source

Department of Pediatrics, University of Louisville School of Medicine, KY 40292.

Abstract

Glycoprotein B (gB) of human cytomegalovirus (HCMV) was partially purified by lentil-lectin column chromatography from cells infected with an adenovirus-gB recombinant. This antigen, which contained specifically reactive proteins of approximately 130 and 55 kDa, was used to investigate gB antibody levels after natural HCMV infection in 48 individuals. All sera had IgG antibody to gB as detected by radioimmunoprecipitation (RIP) assays. Quantitative RIP showed a strong correlation between gB antibody and neutralizing activity (r = .74, P less than .001) but a weak correlation between gB antibody and total HCMV-specific IgG (r = .36, P less than .02). When gB antibody was specifically absorbed from 20 serum specimens, neutralizing antibody titer was reduced a median of 48% (range, 0-98%). These data confirmed that antibodies to gB are a large component of the neutralizing antibody response to HCMV and support a role for this protein in the development of subunit vaccines.

PMID:: 1309850; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Cytomegalovirus Infections - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection. [J Clin Virol. 2000]
Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
Alberola J, Tamarit A, Igual R, Navarro D. J Clin Virol. 2000 Apr; 16(2):113-22.
Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients. [Viral Immunol. 2000]
Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients.
Marshall GS, Li M, Stout GG, Louthan MV, Duliège AM, Burke RL, Hunt LA. Viral Immunol. 2000; 13(3):329-41.
Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques. [J Gen Virol. 2003]
Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
Yue Y, Zhou SS, Barry PA. J Gen Virol. 2003 Dec; 84(Pt 12):3371-9.
Ontogeny of glycoprotein gB-specific antibody and neutralizing activity during natural cytomegalovirus infection. [J Med Virol. 1994]
Ontogeny of glycoprotein gB-specific antibody and neutralizing activity during natural cytomegalovirus infection.
Marshall GS, Stout GG, Knights ME, Rabalais GP, Ashley R, Miller H, Rossier E. J Med Virol. 1994 May; 43(1):77-83.
Review Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens. [Clin Investig. 1993]
Review Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
Weber B, Braun W, Cinatl J Jr, Doerr HW. Clin Investig. 1993 Apr; 71(4):270-6.

See reviews... See all...

Cited by 19 PubMed Central articles

B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. [PLoS Pathog. 2011]
B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.
Pötzsch S, Spindler N, Wiegers AK, Fisch T, Rücker P, Sticht H, Grieb N, Baroti T, Weisel F, Stamminger T, et al. PLoS Pathog. 2011 Aug; 7(8):e1002172. Epub 2011 Aug 11.
Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum. [Clin Vaccine Immunol. 2010]
Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum.
Hackett DJ, Zhang C, Stefanescu C, Pass RF. Clin Vaccine Immunol. 2010 May; 17(5):836-9. Epub 2010 Mar 10.
Review Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant. [J Clin Virol. 2009]
Review Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant.
Pass RF. J Clin Virol. 2009 Dec; 46 Suppl 4:S73-6. Epub 2009 Jul 31.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Antibodies to recombinant-derived glycoprotein B after natural human cytomegalov...
Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.
J Infect Dis. 1992 Feb ;165(2):381-4.

PubMed
The deployment of sensory nerve endings at the knee joint of the cat.
The deployment of sensory nerve endings at the knee joint of the cat.
Acta Physiol Scand. 1953 ;28(4):8287-96.

PubMed
Plasminogen activators and their inhibitors in arthritic disease.
Plasminogen activators and their inhibitors in arthritic disease.
Ann N Y Acad Sci. 1992 Dec 4 ;667:87-100.

PubMed
Length of life and cause of death in rheumatoid arthritis.
Length of life and cause of death in rheumatoid arthritis.
N Engl J Med. 1953 Oct 1 ;249(14):553-6.

PubMed
Cytokine inter-relationships and their association with disease activity in arth...
Cytokine inter-relationships and their association with disease activity in arthritis.
Br J Rheumatol. 1992 Nov ;31(11):725-33.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 19 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information